Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Condition(s):HIV; HIV InfectionsLast Updated:March 2, 2020Completed
Hide Studies Not Open or Pending
Condition(s):HIV; HIV InfectionsLast Updated:March 2, 2020Completed
Condition(s):HIV; HIV InfectionsLast Updated:April 13, 2021Completed
Condition(s):HIV; HIV InfectionsLast Updated:March 2, 2020Completed
Condition(s):Rheumatoid ArthritisLast Updated:July 21, 2016Terminated
Condition(s):Diffuse Large B-Cell Lymphoma, Non-Hodgkin’s LymphomaLast Updated:January 23, 2018Completed
Condition(s):InfluenzaLast Updated:November 1, 2021Completed
Condition(s):Breast CancerLast Updated:April 4, 2022Completed
Condition(s):Breast NeoplasmsLast Updated:April 27, 2021Completed
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:May 2, 2016Completed
Condition(s):Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion; Wet Age Related Macular Degeneration; Diabetic Macular Edema; Retinal Vein OcclusionLast Updated:May 23, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.